Materialise Reports Third Quarter 2023 Results

The conference call will also be broadcast live over the Internet with an accompanying slide presentation, which can be accessed on the company’s website at http://investors.materialise.com. A webcast of the conference call will be archived on the company's website for one year.

About Materialise

Materialise incorporates 30 years of 3D printing experience into a range of software solutions and 3D printing services, which form the backbone of the 3D printing industry. Materialise’s open and flexible solutions enable players in a wide variety of industries, including healthcare, automotive, aerospace, art and design, and consumer goods, to build innovative 3D printing applications that aim to make the world a better and healthier place. Headquartered in Belgium, with branches worldwide, Materialise combines one of the largest groups of software developers in the industry with one of the largest 3D printing facilities in the world. For additional information, please visit: www.materialise.com.

Cautionary Statement on Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prospects, both financial and business, including statements concerning, among other things, our estimates for the current fiscal year’s revenue and Adjusted EBITDA, our results of operations, cash needs, capital expenditures, expenses, financial condition, liquidity, prospects, growth and strategies (including how our business, results of operations and financial condition could be impacted by the current armed conflicts in Israel and Ukraine and governmental responses thereto, inflation, increased labor, energy and materials costs), and the trends and competition that may affect the markets, industry or us. Such statements are subject to known and unknown uncertainties and risks. When used in this press release, the words “estimate,” “expect,” “anticipate,” “project,” “plan,” “intend,” “believe,” “forecast,” “will,” “may,” “could,” “might,” “aim,” “should,” and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon the expectations of management under current assumptions at the time of this press release. These expectations, beliefs and projections are expressed in good faith and the company believes there is a reasonable basis for them. However, the company cannot offer any assurance that our expectations, beliefs and projections will actually be achieved. By their nature, forward-looking statements involve risks and uncertainties because they relate to events, competitive dynamics and industry change, and depend on economic circumstances that may or may not occur in the future or may occur on longer or shorter timelines than anticipated. We caution you that forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. All of the forward-looking statements are subject to risks and uncertainties that may cause the company's actual results to differ materially from our expectations, including risk factors described in the company's most recent annual report on Form 20-F filed with the U.S. Securities and Exchange Commission. There are a number of risks and uncertainties that could cause the company's actual results to differ materially from the forward-looking statements contained in this press release.

The company is providing this information as of the date of this press release and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise, unless it has obligations under the federal securities laws to update and disclose material developments related to previously disclosed information.

Consolidated income statements (Unaudited)

 

for the three months ended

September 30,

 

for the nine months ended

September 30,

In '000

2023

 

2023

 

2022

 

2023

 

2022

U.S.$
Revenue

63,702

60,130

58,288

190,832

169,319

Cost of Sales

(28,005)

(26,435)

(26,245)

(83,249)

(76,236)

Gross Profit

35,697

33,696

32,042

107,583

93,083

Gross profit as % of revenue

56.0%

56.0%

55.0%

56.4%

55.0%

 
Research and development expenses

(10,039)

(9,476)

(9,313)

(27,982)

(26,074)

Sales and marketing expenses

(14,789)

(13,960)

(15,198)

(42,418)

(44,841)

General and administrative expenses

(9,153)

(8,640)

(8,980)

(27,213)

(26,089)

Net other operating income (expenses)

753

710

1,166

(3,238)

2,603

Operating (loss) profit

2,469

2,330

(282)

6,732

(1,318)

 
Financial expenses

(1,646)

(1,554)

(2,110)

(3,599)

(4,671)

Financial income

3,043

2,873

4,283

4,987

9,800

Share in loss of joint venture

-

-

-

-

-

(Loss) profit before taxes

3,866

3,649

1,891

8,120

3,812

 
Income Taxes

385

363

(478)

(886)

(1,377)

Net (loss) profit for the period

4,251

4,013

1,413

7,234

2,435

Net (loss) profit attributable to:

-

The owners of the parent

4,256

4,017

1,421

7,251

2,457

Non-controlling interest

(5)

(5)

(8)

(17)

(21)

 
Earning per share attributable to owners of the parent
Basic

0.07

0.07

0.02

0.12

0.04

Diluted

0.07

0.07

0.02

0.12

0.04

 
Weighted average basic shares outstanding

59,067

59,067

59,064

59,067

59,064

Weighted average diluted shares outstanding

59,068

59,068

59,089

59,070

59,099

Consolidated statements of comprehensive income (Unaudited)

 

for the three months ended

September 30,

 

for the nine months ended

September 30,

In 000€

2023

 

2023

 

2022

 

2023

 

2022

U.S.$

 

 

 

 

Net profit (loss) for the period

4,251

4,013

1,413

7,234

2,435

Other comprehensive income
Recycling
Exchange difference on translation of foreign operations

(816)

(770)

225

471

1,291

Non-recycling
Fair value adjustments through OCI - Equity instruments

-

-

-

-

-

Other comprehensive income (loss), net of taxes

(816)

(770)

225

471

1,291

Total comprehensive income (loss) for the year, net of taxes

3,435

3,242

1,638

7,705

3,726

Total comprehensive income (loss) attributable to:
The owners of the parent

3,441

3,248

1,646

7,721

3,748

Non-controlling interests

(6)

(5)

(8)

(15)

(21)

Consolidated statement of financial position (Unaudited)

 

As of

September 30,

 

As of

December 31,

In 000€

2023

 

2022

Assets
Non-current assets
Goodwill

44,280

44,155

Intangible assets

35,592

37,875

Property, plant & equipment

94,399

94,276

Right-of-Use assets

7,668

8,420

Investments in joint ventures

-

-

Deferred tax assets

2,031

1,186

Investments in convertible loans

3,681

3,494

Investments in non-listed equity instruments

307

307

Other non-current assets

5,213

5,136

Total non-current assets

193,170

194,847

Current assets
Inventories

16,764

16,081

Trade receivables

41,998

51,043

Other current assets

8,107

8,424

Cash and cash equivalents

133,953

140,867

Total current assets

200,821

216,414

Total assets

393,991

411,262

As of

September 30,

 

As of

December 31,

In 000€

2023

 

2022

Equity and liabilities
Equity
Share capital

4,487

4,487

Share premium

233,895

233,895

Retained earnings and other reserves

(1,708)

(9,427)

Equity attributable to the owners of the parent

236,674

228,955

Non-controlling interest

(43)

(28)

Total equity

236,631

228,928

Non-current liabilities
Loans & borrowings

45,204

55,873

Lease liabilities

5,053

5,147

Deferred tax liabilities

3,786

4,312

Deferred income

8,533

9,277

Other non-current liabilities

1,185

1,611

Total non-current liabilities

63,761

76,220

Current liabilities
Loans & borrowings

13,491

17,058

Lease liabilities

2,474

2,902

Trade payables

20,799

23,230

Tax payables

2,273

1,246

Deferred income

37,940

41,721

Other current liabilities

16,622

19,957

Total current liabilities

93,599

106,114

Total equity and liabilities

393,991

411,262

Consolidated statement of cash flows (Unaudited)

 

for the nine months ended

September 30,

In 000€

2023

 

2022

Operating activities
Net (loss) profit for the period

7,234

2,435

Non-cash and operational adjustments
Depreciation of property plant & equipment

11,162

11,335

Amortization of intangible assets

5,046

4,859

Impairment of goodwill and intangible assets

-

-

Share-based payment expense

-

(121)

Loss (gain) on disposal of intangible assets and property, plant & equipment

(401)

59

Movement in provisions

(434)

(506)

Movement reserve for bad debt and slow moving inventory

445

(42)

Financial income

(4,811)

(9,771)

Financial expense

3,389

5,009

Impact of foreign currencies

(152)

98

(Deferred) income taxes

892

1,384

Working capital adjustments

(3,601)

9,109

Decrease (increase) in trade receivables and other receivables

8,965

(184)

Decrease (increase) in inventories and contracts in progress

(751)

(4,356)

Increase (decrease) in deferred revenue

(4,532)

3,815

Increase (decrease) in trade payables and other payables

(7,283)

9,834

Income tax paid & Interest received

1,194

(262)

Net cash flow from operating activities

19,963

23,587

for the nine months ended

September 30,

In 000€

2023

 

2022

Investing activities
Purchase of property, plant & equipment

(6,862)

(16,066)

Purchase of intangible assets

(2,448)

(3,422)

Proceeds from the sale of property, plant & equipment & intangible assets (net)

645

319

Acquisition of subsidiary (net of cash)

-

(29,355)

Net cash flow used in investing activities

(8,665)

(48,523)

Financing activities
Repayment of loans & borrowings

(14,334)

(15,182)

Repayment of leases

(2,640)

(2,566)

Capital increase

-

-

Interest paid

(1,334)

(1,665)

Other financial income (expense)

(25)

1,378

Net cash flow from (used in) financing activities

(18,334)

(18,035)

Net increase/(decrease) of cash & cash equivalents

(7,037)

(42,972)

Cash & Cash equivalents at the beginning of the year

140,867

196,028

Exchange rate differences on cash & cash equivalents

123

(2,433)

Cash & cash equivalents at end of the period

133,953

150,621

Reconciliation of Net Profit (Loss) to EBITDA and Adjusted EBITDA (Unaudited)

 

for the three months ended

September 30,

 

for the nine months ended

September 30,

In 000€

2023

 

2022

 

2023

 

2022

Net profit (loss) for the period

4,013

1,413

7,234

2,435

Income taxes

(363)

478

886

1,377

Financial expenses

1,554

2,110

3,599

4,671

Financial income

(2,873)

(4,283)

(4,987)

(9,800)

Depreciation and amortization

5,527

5,378

16,191

16,194

EBITDA

7,857

5,096

22,923

14,876

Share-based compensation expense (1)

-

(24)

-

(121)

Adjusted EBITDA

7,857

5,072

22,923

14,755

 
(1) Share-based compensation expense represents the cost of equity-settled and share-based payments to employees.

Segment P&L (Unaudited)

 

In 000€

Materialise

S oftware

Materialise

M edical

Materialise

M anufacturing

Total

s egments

Unallocated (1)

Consolidated

For the three months ended September 30, 2023
Revenues

10,811

24,263

25,056

60,130

0

60,130

Segment (adj) EBITDA

1,781

7,143

1,074

9,998

(2,141)

7,857

Segment (adj) EBITDA %

16.5%

29.4%

4.3%

16.6%

13.1%

For the three months ended September 30, 2022
Revenues

10,863

21,391

26,033

58,288

0

58,288

Segment (adj) EBITDA

202

4,765

2,530

7,497

(2,425)

5,072

Segment (adj) EBITDA %

1.9%

22.3%

9.7%

12.9%

8.7%

 

In 000€

Materialise

S oftware

Materialise

M edical

Materialise

M anufacturing

Total

s egments

Unallocated (1)

Consolidated

For the nine months ended September 30, 2023
Revenues

33,192

73,528

84,112

190,832

0

190,832

Segment (adj) EBITDA

6,190

17,179

6,980

30,349

(7,426)

22,923

Segment (adj) EBITDA %

18.7%

23.4%

8.3%

15.9%

12.0%

For the nine months ended September 30, 2022
Revenues

31,989

60,592

76,739

169,319

0

169,319

Segment (adj) EBITDA

2,955

12,466

6,722

22,144

(7,388)

14,755

Segment (adj) EBITDA %

9.2%

20.6%

8.8%

13.1%

8.7%

 
(1) Unallocated segment adjusted EBITDA consists of corporate research and development and corporate other operating income (expense), and the added share-based compensation expenses, acquisition related expenses of business combinations, impairments and fair value of business combinations that are included in Adjusted EBITDA.

Reconciliation of Net Profit (Loss) to Segment adjusted EBITDA (Unaudited)

 

for the three months ended

September 30,

 

for the nine months ended

September 30,

In 000€

2023

 

2022

 

2023

 

2022

Net profit (loss) for the period

4,013

1,413

7,234

2,435

Income taxes

(363)

478

886

1,377

Financial cost

1,554

2,110

3,599

4,671

Financial income

(2,873)

(4,283)

(4,987)

(9,800)

Operating (loss) profit

2,330

(282)

6,732

(1,318)

Depreciation and amortization

5,527

5,378

16,191

16,194

Corporate research and development

604

592

2,063

2,057

Corporate headquarter costs

2,399

2,491

7,636

7,103

Other operating income (expense)

(862)

(681)

(2,274)

(1,892)

Segment adjusted EBITDA

9,998

7,497

30,349

22,144





© 2024 Internet Business Systems, Inc.
670 Aberdeen Way, Milpitas, CA 95035
+1 (408) 882-6554 — Contact Us
ShareCG™ is a trademark of Internet Business Systems, Inc.

Report a Bug Report Abuse Make a Suggestion About Privacy Policy Contact Us User Agreement Advertise